Friday, October 30, 2026
  • Politics
  • Lifestyle
  • Business
  • Medical
  • Shop
No Result
View All Result
  • Politics
  • Lifestyle
  • Business
  • Medical
  • Shop
No Result
View All Result
No Result
View All Result
Home Lifestyle

CBD is Invading Over-The-Counter Retail Stores. And Consumers Love It.

by Deanna deBara
June 25, 2019
in Lifestyle, Medical Marijuana, Politics
0
CBD is Invading Over-The-Counter Retail Stores. And Consumers Love It.
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

As medical and recreational legalization of cannabis continues to make weed more mainstream,  more consumers are shifting their views on the plant, and retailers are taking notice.

Cannabis — and, in particular, cannabidiol (CBD) — is poised to become one of the most popular and financially successful sectors of consumer processed goods. Most experts project its potential well into the billions of dollars.

As CBD continues to rise in popularity, more over-the-counter (OTC) retailers are getting on board — and shifting their strategies to accommodate this new market. “A lot of the products that are widely available in OTC stores have been available for 10 to 15 years, so [CBD] brings new solutions to the space and…new interest, which has been well received by the retailers,” said Dustin Sullivan, chief operating officer of CBD Unlimited and a veteran retail business development professional.

But how, exactly, are cannabis and CBD changing the consumer processed goods industry? How do consumers feel about the emerging CBD market? And how can brands and over-the-counter retailers tap into this new market?

Consumer Perception in Over-The-Counter Retailers

It’s only been very recently that CBD products, such as topicals and tinctures, have been sold at over-the-counter retailers. But according to a May 2019 survey from Nielsen, it’s a welcome change — and consumers are embracing the shift towards hemp-derived CBD products, particularly when it comes to using CBD for medicinal purposes.

As CBD becomes more widely available at over-the-counter retailers and legalization becomes more likely, consumers are considering cannabis as an alternative treatment for health issues, including chronic pain. According to the Nielsen survey, 40% of all headache and migraine sufferers, 40% of all arthritic pain sufferers, and 41% of all back and neck pain sufferers are interested in consuming cannabis as an alternative pain treatment. The survey notes that while there are a few exceptions, the majority of those surveyed with chronic pain are currently using OTC or prescription treatments.

Changing consumer perception are helping fuel increased interest in cannabis and CBD. Of the people surveyed who are currently treating their ailments with OTC or prescription medicines and who said they’d be interested in trying cannabis alternatives, 67% said they’d rather use cannabis because they believe it’s more healthful, 69% said they consider it more natural, and just less than 50% said they would consider using cannabis as an alternative to their OTC or prescription regimen because they perceive it to be more cost-effective.

The bottom line? Consumer demand for over-the-counter CBD and cannabis products is there — and retailers will need to legally embrace the trend in order to keep up with that demand. 

Unique Challenges Facing CBD Industry as it Moves into Over-The-Counter

Currently, the only products that are approved across the U.S. for sale over the counter are hemp-derived CBD products containing less than 0.3% THC. But even though it is legal, that doesn’t mean the industry is without its challenges.

“I think one of the biggest challenges that brands are facing right now is not knowing how to label their products,” said Katie DeVoe, co-founder of white-label CBD manufacturer CBDNationwide. 

Because CBD is new to the over-the-counter market, regulations can shift without notice — which can cause issues with packaging on the brand side. For example, “[certain states] will no longer allow for the word ‘CBD’ to be on any package, and only can have ‘hemp,’ ” DeVoe said, “where other states … want CBD to be the big callout, so that leaves a lot of confusion.” 

CBD brands also have to be careful about the claims they make on their packaging. The Food and Drug Administration (FDA) has been cracking down on CBD products that make unsubstantiated medical claims — which is why more companies are making a shift toward focusing on ingredients.

“I think rather than making those specific call-outs that are a claim like ‘pain fighting’ or ‘anxiety reliever’ or ‘antidepressant,’ it’s more now looking at the call-out of the actual ingredients that are being used in the product,” Sullivan said.

The biggest challenge is the educational element, Sullivan added. Because CBD products don’t have the kind of familiarity as more traditional over-the-counter products, merchandising that places an emphasis on education is a must.

“[Retailers] may place [the CBD products] in several areas within the store, but each location is going to have to be really clear with how they present the educational material around the product,” Sullivan said.

CBD’s Future in Over-The-Counter Retailers

Challenges aside, it appears as though CBD products for sale over the counter are here to stay. As CBD continues to rise in popularity and legalization spreads, the number of hemp and cannabis products on OTC retail shelves is likely to increase. 

“A lot more folks are coming on board, but the people who are going to win long term are the ones who are quickly becoming experts and informing customers,” Sullivan said.

It’s going to become even more important for retailers to educate themselves — and their customers — on how to make informed decisions about CBD products, considering the cost and what’s inside each milligram.


Feature Image: As a new wellness treatment, CBD is poised to become a multi-billion-dollar industry, especially now that it is being sold at major pharmacy chains such as CVS and  Walgreens. (Photo courtesy of Otisfrog on WikiMedia Commons)

Views: 1178
Previous Post

CBD For Anxiety, Does It Work?

Next Post

More Weed, Less Booze? Researchers Examine Which Way Consumption Goes.

Deanna deBara

Related Posts

Cannabis Policy Influences Voter Decisions: 78% of Consumers Say It’s a Dealbreaker

Cannabis Policy Influences Voter Decisions: 78% of Consumers Say It’s a Dealbreaker

by Keegan MacDonald
October 28, 2026
0

Where Things Stand: Cannabis Policy as a Political Litmus TestA recent poll conducted among cannabis consumers reveals a striking statistic:...

Virginia Lawmaker Indicted in Federal Marijuana Trafficking Case: What It Means for Cannabis Policy

Virginia Lawmaker Indicted in Federal Marijuana Trafficking Case: What It Means for Cannabis Policy

by Keegan MacDonald
October 28, 2026
0

The Arrest That Shakes Virginia’s Cannabis LandscapeFederal prosecutors have indicted a sitting Virginia state lawmaker on charges related to a...

Majority of Military Veterans Back Legal Marijuana for Both Medical and Recreational Use, Poll Finds

Majority of Military Veterans Back Legal Marijuana for Both Medical and Recreational Use, Poll Finds

by Keegan MacDonald
October 28, 2026
0

Shifting Perspectives Among Veterans on Marijuana LegalizationA recent nationwide poll sheds light on the changing views of military veterans toward...

Trump’s Marijuana Rescheduling Delays Are Costing Him Support Among Cannabis Consumers

Trump’s Marijuana Rescheduling Delays Are Costing Him Support Among Cannabis Consumers

by Keegan MacDonald
October 28, 2026
0

Slow Progress, Growing FrustrationPresident Trump’s administration has faced mounting criticism from marijuana consumers due to repeated delays in rescheduling cannabis...

Next Post
More Weed, Less Booze? Researchers Examine Which Way Consumption Goes.

More Weed, Less Booze? Researchers Examine Which Way Consumption Goes.

Is a rise in heart attacks linked to cannabis legalization?

Is a rise in heart attacks linked to cannabis legalization?

October 30, 2026
Cannabis Policy Influences Voter Decisions: 78% of Consumers Say It’s a Dealbreaker

Cannabis Policy Influences Voter Decisions: 78% of Consumers Say It’s a Dealbreaker

October 28, 2026
Virginia Lawmaker Indicted in Federal Marijuana Trafficking Case: What It Means for Cannabis Policy

Virginia Lawmaker Indicted in Federal Marijuana Trafficking Case: What It Means for Cannabis Policy

October 28, 2026
ADVERTISEMENT
Sign up for the PP Newsletter

Categories

  • Age Restrictions
  • Air Travel
  • All Categories
  • American Culture
  • Animal Health
  • Anxiety
  • Anxiety Relief
  • Ballot Initiative
  • Bioplastics
  • Bipartisan Bill
  • Bipartisan Politics
  • Brain Science
  • Business
  • Canada
  • Cancer
  • Cancer Care
  • Cancer Treatment
  • Cannabinoid Receptors
  • Cannabinoids
  • cannabis
  • Cannabis Banking
  • Cannabis Brands
  • Cannabis Business
  • Cannabis Compliance
  • Cannabis Consumers
  • Cannabis Culture
  • Cannabis Extraction
  • Cannabis Finance
  • Cannabis Health Risks
  • Cannabis History
  • Cannabis Industry
  • Cannabis Legalization
  • Cannabis Legislation
  • Cannabis Market
  • Cannabis Mergers
  • Cannabis Policy
  • Cannabis Reform
  • Cannabis Regulation
  • Cannabis Research
  • Cannabis Tax
  • Cannabis Taxation
  • Cannabis Tourism
  • Cannabis Travel
  • Cannabis Trends
  • Cannabis Use Disorder
  • Cardiovascular Effects
  • CB1 Receptor
  • CB2 Receptor
  • CBD
  • China
  • Cigarette Smoking
  • College Tuition
  • Colorado
  • Congress
  • Congressional Amendment
  • Consumer Health
  • Controlled Substances Act
  • Criminal Justice
  • Criminal Justice Reform
  • Culture
  • DEA
  • Deceptive Marketing
  • Delaware
  • Democrats
  • Dispensary Closures
  • DMV Region
  • Donald Trump
  • Drug Policy
  • Drug Reform
  • Elections
  • Employment Law
  • Endocannabinoid System
  • Entourage Effect
  • Environment
  • Farm Bill
  • FBI Data
  • FDA
  • Featured
  • Federal Cannabis Law
  • Federal Cannabis Policy
  • Federal Indictment
  • Federal Law
  • Federal Lawsuit
  • Federal Regulation
  • Federally Funded Study
  • Financial Services
  • Foreign Investment
  • Georgia
  • Glioblastoma
  • GOP Senators
  • Green Thumb Industries
  • Gun Rights
  • Health Research
  • Health Studies
  • Heart Health
  • Hemp
  • Hemp Business
  • Hemp Cultivation
  • Hemp Market
  • Hemp Regulation
  • Hemp-Derived THC
  • Illegal Market
  • Industry Risks
  • Insomnia
  • Investors
  • Jeff Sessions
  • Job Loss
  • John Fetterman
  • John Hickenlooper
  • John James
  • Kratom
  • Law Enforcement
  • Lawmakers
  • Legal Cannabis Industry
  • Legal Compliance
  • Legal Precedent
  • Legalization
  • Legislation
  • Lifestyle
  • Lower Back Pain
  • Marijuana
  • Marijuana Arrests
  • Marijuana Business
  • Marijuana Clemency
  • Marijuana Descheduling
  • Marijuana Extracts
  • Marijuana IPOs
  • Marijuana Legalization
  • Marijuana Policy
  • Marijuana Reform
  • Marijuana Regulation
  • Marijuana Rescheduling
  • Marijuana Safety
  • Marijuana Tax
  • Marijuana Trafficking
  • Marijuana Use
  • Marijuana Users
  • Marijuana Withdrawal
  • Market Trends
  • Maryland
  • Massachusetts
  • Medical
  • Medical Cannabis
  • Medical Claims
  • Medical Marijuana
  • Medical Research
  • Mental Health
  • Michael Bennet
  • Michael Douglas
  • Michigan
  • Michigan Cannabis
  • Military Veterans
  • MJBizDaily
  • Mood Disorders
  • MSOs
  • Nasdaq
  • National Security
  • New Jersey
  • Nightmares
  • North Carolina
  • NYSE
  • Oklahoma
  • Older Adults
  • Opioid Reduction
  • Overdose Myths
  • Packaging
  • Pain Management
  • Patient Care
  • Pets
  • Police Search
  • Policy
  • Politics
  • Potent Cannabis
  • Pre-rolls
  • Product Safety
  • Psychedelics
  • PTSD
  • Public Education
  • Public Health
  • Public Listings
  • Public Safety
  • Rand Paul
  • Recreational Cannabis
  • Recreational Marijuana
  • Regulation
  • Regulatory Challenges
  • Regulatory Compliance
  • Research
  • Retail Cannabis
  • Retail Strategy
  • SAFE Banking Act
  • Second Amendment
  • Senior Marijuana Use
  • Sharon Stone
  • Sleep Disorders
  • Small Business
  • SNDL
  • Social Equity
  • State Budget
  • State Cannabis Officials
  • State Cannabis Policy
  • State Lawmakers
  • State Legalization
  • State Legislation
  • Substance Use
  • Supreme Court
  • Sustainability
  • Symptom Management
  • Tax Dispute
  • Terpenes
  • Testosterone
  • THC
  • THC Potency
  • THC Products
  • Trump Administration
  • TSA
  • U.S. Cannabis Industry
  • U.S. Hemp Industry
  • U.S. Senate
  • uncategorized
  • Underage Cannabis Use
  • Uplisting
  • US Cannabis
  • US Cannabis Market
  • US Politics
  • US Study
  • USPS
  • Veterans
  • Veterans Affairs
  • Veterinarians
  • Veterinary Medicine
  • Virginia
  • Voting Behavior
  • World Cup 2024
  • Young Men

Recent Posts

  • Is a rise in heart attacks linked to cannabis legalization?
  • Cannabis Policy Influences Voter Decisions: 78% of Consumers Say It’s a Dealbreaker

Browse by Tag

420 cannabis Edibles Legalization marijuana NORML THC

AFFILIATES

© Pot Portal. All rights reserved.

No Result
View All Result

© Pot Portal. All rights reserved.